Efficacy and Tolerability of Biweekly Bevacizumab, Irinotecan, Folinic Acid and Fluorouracil Intravenous Bolus (BIFF Regimen) in Patients With Metastatic Colorectal Cancer: The Southern Italy Cooperative Oncology Group Experience
- 1 March 2011
- journal article
- Published by Elsevier BV in Clinical Colorectal Cancer
- Vol. 10 (1), 42-47
- https://doi.org/10.3816/ccc.2011.n.006
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III StudyJournal of Clinical Oncology, 2008
- Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Updated Results From the BICC-C StudyJournal of Clinical Oncology, 2008
- Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Results From the BICC-C StudyJournal of Clinical Oncology, 2007
- Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and AngiogenesisJournal of Clinical Oncology, 2005
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal CancerThe New England Journal of Medicine, 2004
- Targeted Therapy of Colorectal Cancer: Clinical Experience with BevacizumabThe Oncologist, 2004
- Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in TumorsCancer Research, 2004
- Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11British Journal of Cancer, 2003
- Addition of either irinotecan or methotrexate to bolus5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology GroupAnnals of Oncology, 2002
- Angiogenesis in cancer and other diseasesNature, 2000